Providence hires new team, expands neuro-oncology program

June 28, 2022 Providence inScope Content Team

Author: John Zurasky, M.D., medical director, Providence Brain and Spine Institute

The Providence neuro-oncology program provides compassionate care to some of our community’s most vulnerable patients. We help patients understand their treatment options and quality of life considerations so they can make informed decisions in partnership with their care team and loved ones.

Prakash Ambady, M.D., and his interdisciplinary team of providers, nurses, and social work support will be located at Providence Neurological Specialties - West. This team will collaborate with providers from Providence Cancer Institute to provide oncology care and will offer cutting-edge clinical trial opportunities through both Providence Brain and Spine Institute Clinical Research and the Earle A. Chiles Research Institute, a division of Providence Cancer Institute.

Dr. Ambady’s training and experience include:

Neurology training at Drexel University College of Medicine
Training at Johns Hopkins University and the National Institutes of Health
Seven years of experience building a strong program and staff at OHSU, where he served as associate professor
An active research portfolio, including investigator-initiated trials and an NIH-supported study

In addition, Dr. Ambady joins Providence Brain and Spine Institute’s Virtual Second Opinion Service, which offers patients low-cost, convenient access to experts in brain tumors, Moyamoya disease and cerebral aneurysms.

KATU - Providence neuro-oncology, expanded services

More information
Dr. Ambady and the neuro-oncology team are now seeing patients. For more information, contact the clinic at 503-216-1150 or learn more at Neuro-Oncology Program | Providence.

Neuro-oncology providers

Prakash Ambady, M.D., neuro-oncology physician
Dana Moussalli, AGACNP, neuro-oncology nurse practitioner
Lauren Popp, FNP, neuro-oncology nurse practitioner

Neuro-oncology clinic team

Briana Camp, neuro-oncology scheduling coordinator
Verda Dew, neuro-oncology social worker
Julie Peterson, neuro-oncology medical assistant
Maria Turchan, RN, neuro-oncology nurse

About the Author

The inScope content team focuses on bringing you the latest in clinical news from our team of world-class medical providers and physician leaders.
More Content by Providence inScope Content Team

Welcome to your journey for creating a healthier you

Providence hires new team, expands neuro-oncology program

About the Author

Previous Article

Next Article

Providence hires new team, expands neuro-oncology program

About the Author

Previous Article

Next Article

Most Recent Articles

The Gamma Knife Esprit stereotactic radiosurgery system moves beyond a fixed headframe to target the most challenging areas of the brain with exceptional accuracy.

Thousands upon thousands of cancer patients and family members at Providence have benefited from the life-changing work of Dr. Walter Urba. Learn about his remarkable career.

What is required to make clinical trials accessible to people in Hood River and other Columbia Gorge communities? Learn more about why it's important to expand access to studies and cancer care.

This prestigious award recognizes Dr. Fox’s extraordinary contributions to the field of immunotherapy and his lifelong dedication to advancing cancer research.

A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model that will lay the foundation to improve patient outcomes.

Years after the start of the pandemic, more than 200 patients continue to be cared for at Providence for ongoing symptoms that remain from contracting COVID-19. Learn how Providence continues helping.

A new investigator-initiated study for patients with metastatic melanoma and HNSCC aims to evaluate a galectin-3 inhibitor as a way to “remove the brakes” from the immune system.

The advent of MRI scanning of the brain and spinal cord was a giant leap forward in improving the ability to diagnose multiple sclerosis with greater sensitivity and reliability.

Growing the surgical oncology programs at Providence Cancer Institute is a testament to our commitment to providing research-focused, comprehensive services and improving outcomes for patients.

During winter months when the days are shorter and darker, both postpartum depression and baby blues may be more difficult.

A study led by Dr. Christopher Darus may offer hope to women with persistent endometrial cancer. Currently, the prognosis is poor for women with this form of cancer.

Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

Being able to assess the level of fibrosis and make appropriate referrals is important in the care of patients with Steatotic Liver Disease (formerly known as Fatty Liver).